Tiazac Capsule, Extended Release
Product Images NDC 0187-2613

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tiazac (NDC 0187-2613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
TIAZAC is a prescription drug containing diltiazem hydrochloride in an extended-release capsule form. It comes in a bottle containing 30 capsules, with each capsule containing 120 mg of the drug. The drug should not be taken if the bottle's seal is broken. It is manufactured by a company called BAUSCH Health Companies Inc. The text also includes some unreadable characters.*
FDA Label Image

Image 02

Image 02
This is a description of TIAZAC, a medication that comes in 180 mg extended-release capsules. It contains diltiazem hydrochloride and is only available via prescription. The medication is manufactured by Companies Inc. and should not be used if the bottle closure seal is broken. The drug release test meets the standards set by the USP. A bottle contains 30 capsules.*
FDA Label Image

Image 03

Image 03
This is a prescription drug with NDC number 0187-2614-30 from a pharmaceutical company called Bausch Health. The drug is Tiazac, which contains 240mg of diltiazem hydrochloride in extended-release capsules form. The label warns not to use if the bottle closure seal is broken.*
FDA Label Image

Image 04

Image 04
This is a description of a medication called TIAZAC (diltiazem hydrochloride) which is available in a bottle containing 30 extended-release capsules of 300 mg each. The medication is prescription-only and its National Drug Code (NDC) is 0187-2615-30. The manufacturer of the medication is not clear from the text as the term "BAUSCHE-Health" could refer to the capsule's contents or bottle closure. The text also reminds the user not to use the product if the bottle closure seal is broken.*
FDA Label Image

Image 05

Image 05
This is a description of a prescription drug container - TIAZACĀ® (diltiazem hydrochloride) extended-release capsules of 420 mg strength. The National Drug Code (NDC) number for the product is 0187-2617-30 and it is for Rx-only use. There is a safety closure on the bottle, and the package contains 30 capsules.*
FDA Label Image

Image 06

Image 06
TIAZACĀ® (diltiazem hydrochloride) is a prescription drug available in extended-release capsules form. The capsules contain 360 mg of the medication and are supplied in a bottle containing 30 capsules. The medication is used for the treatment of hypertension and other heart-related conditions. Users are cautioned not to use the medication if the bottle closure seal is tampered with. The bottle is fitted with safety closures for user safety purposes.*
FDA Label Image

Chemical Structure (Tiazac 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.